Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 11 October 2005
Vol. 2005, Issue 305, p. tw358
[DOI: 10.1126/stke.3052005tw358]

EDITORS' CHOICE

NEUROBIOLOGY Helping Neuronal Repair

Regeneration of axons in the central nervous system after injury is limited, in part because of inhibitory signals derived from myelin and glia. Koprivica et al. (see the news story by Miller) screened a bank of small molecules to identify molecules that might alleviate the inhibition. The results implicate the epidermal growth factor receptor (EGFR) in the endogenous signaling that allows myelin to block neurite outgrowth. Of about 400 small molecules screened, tyrphostin variants seemed particularly effective. Because EGFR inhibitors are already in clinical use for cancer patients, it is possible that these findings could be exploited rapidly in the treatment of neuronal injury.

V. Koprivica, K.-S. Cho, J. B. Park, G. Yiu, J. Atwal, B. Gore, J. A. Kim, E. Lin, M. Tessier-Lavigne, D. F. Chen, Z. He, EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310, 106-110 (2005). [Abstract] [Full Text]

G. Miller, Cancer drugs may help injured nerve cells regrow their axons. Science 310, 31 (2005). [Summary] [Full Text]

Citation: Helping Neuronal Repair. Sci. STKE 2005, tw358 (2005).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882